John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 5,526 shares at $115.70 ($639K) on 2018-02-08, disclosed to the SEC on 2018-02-08.
Seasonal sale ($639k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.70 | 1,200 | $139K | 21.7% |
| 2 | $115.70 | 2,163 | $250K | 39.1% |
| 3 | $115.70 | 2,163 | $250K | 39.1% |
| Total | $115.70 avg | 5,526 | $639K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |
| ALXN | SELL | 2017-02-10 | $21K | — | Filing → |